Quantcast
Last updated on April 17, 2014 at 17:30 EDT

Latest adjuvant therapy Stories

2013-10-22 23:00:54

Nearly 80 percent of women who contacted a patient assistance program had some or all of their needs met, compared with only 35 percent of those who did not New York, New York (PRWEB) October 22, 2013 NEW YORK, NY  – October 22, 2013 /Press Release/  ––  Patient assistance programs can help breast cancer patients meet a variety of needs that can interfere with getting recommended adjuvant therapies such as radiation, chemotherapy, and hormonal treatments,...

2013-10-09 12:49:29

Among patients with pancreatic cancer who had surgery for removal of the cancer, treatment with the drug gemcitabine for 6 months resulted in increased overall survival as well as disease-free survival, compared with observation alone, according to a study in the October 9 issue of JAMA. "Pancreatic cancer is a disease with a poor prognosis, mainly because of the inability to detect the tumor at an early stage, its high potential for early dissemination, and its relatively poor sensitivity...

2013-10-01 04:22:41

Four Studies Presented at the European Cancer Congress, Following NICE's Recommendation for Using Oncotype DX Test to Guide Chemotherapy Decisions in Early-stage Breast Cancer Patients AMSTERDAM and REDWOOD CITY, Calif., Oct. 1, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results from four studies highlighting the value of its Oncotype DX(®) tests for optimizing treatment for patients with breast and colon cancer. Three new decision impact studies - including...

2013-09-24 23:00:29

A highly targeted cancer radiation therapy may offer a safe and effective treatment option for elderly pancreatic cancer patients unable to undergo surgery or combined chemotherapy and radiation therapy, according to researchers at Henry Ford Hospital in Detroit. Detroit, Michigan (PRWEB) September 25, 2013 A highly targeted cancer radiation therapy may offer a safe and effective treatment option for elderly pancreatic cancer patients unable to undergo surgery or combined chemotherapy and...

2013-09-23 13:06:32

Guideline provides detailed direction on treatment options for prostate cancer patients The American Society for Radiation Oncology (ASTRO) will highlight the recently published Adjuvant and Salvage Radiotherapy After Prostatectomy: ASTRO/AUA Guideline during ASTRO’s 55th Annual Meeting, September 22-25, 2013, in Atlanta. The guideline focuses on radiation therapy after prostatectomy for patients with and without evidence of prostate cancer recurrence, and is a joint effort between...

2013-09-18 15:45:20

Results of EORTC trial 10853 appearing in the Journal of Clinical Oncology show that breast conserving treatment combined with radiotherapy reduces the risk of local recurrence in women with ductal carcinoma in situ (DCIS). The incidence of DCIS has been increasing in the past decades, and this has been attributed to increased detection through breast cancer screening using mammograms. In the EORTC study, adjuvant radiotherapy after local excision reduced the incidence of both in situ and...

2013-09-09 16:23:45

Important Role of Molecular Subtyping in Determining the Need for Chemotherapy also Cited IRVINE, Calif. and AMSTERDAM, Sept. 9, 2013 /PRNewswire/ -- Agendia, a leader in molecular cancer diagnostics, today announced that multiple established international breast cancer treatment guidelines confirmed that Agendia's MammaPrint(®) tests, the leading product in Agendia's Symphony suite of breast cancer tests, significantly augment prognostic and predictive information in making key cancer...

2013-06-28 11:35:41

Journal of the American College of Surgeons study author says that patients´ medical follow-up after a melanoma diagnosis should be lifelong Recurrence of melanoma skin cancer 10 or more years after initial treatment is more common than previously thought, occurring in more than one in 20 patients. However, according to a new study, these patients tend to live longer after their cancer returns than patients whose melanoma recurs in the first three years. The study results appear in...

2013-06-11 15:06:16

Parallel imaging improves risk stratification and patient management and hints toward potential benefits of simultaneous PET/MR For patients with advanced breast cancer, positron emission tomography (PET) and magnetic resonance (MR) imaging can improve quality of life and survival by providing physicians with information on the effectiveness of chemotherapy prior to surgery, say researchers presenting at the 2013 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging....

2013-06-03 08:27:25

Previstage(TM )GCC colorectal cancer test featured at the 2013 ASCO Annual Meeting QUEBEC CITY, June 3, 2013 /PRNewswire/ - DiagnoCure Inc. (TSX: CUR) (OTCQX: DGCRF) today reported that results of a new study were presented on Sunday, June 2, during the 2013 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, Illinois. The abstract of the presentation entitled "Guanylyl cyclase C (GCC) expression in lymph nodes (LNs) as a determinant of recurrence in stage...